Maria Antonia De Francesco Selected Research

Anti-Bacterial Agents (Antibiotics)

2/2023	Emergence of Pandemic Clonal Lineage Sequence Types 131 and 69 of Extraintestinal Escherichia coli as a Cause of Meningitis: Is It Time To Revise Molecular Assays?
1/2018	Myroides odoratimimus urinary tract infection in an immunocompromised patient: an emerging multidrug-resistant micro-organism.
8/2015	Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
1/2014	In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
2/2011	Bacterial species present in the lower male genital tract: a five-year retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Antonia De Francesco Research Topics

Disease

6	Infections 07/2020 - 03/2003
2	Disease Progression 01/2023 - 01/2015
2	Hepatitis C 01/2022 - 02/2003
1	Autoimmune Diseases (Autoimmune Disease) 01/2024
1	Liver Abscess 01/2024
1	Amebic Dysentery (Amoebic Dysentery) 01/2024
1	Mycoses (Diseases, Fungus) 10/2023
1	Aspergillosis 10/2023
1	Chickenpox 02/2023
1	Meningitis 02/2023
1	Critical Illness (Critically Ill) 01/2023
1	Superinfection 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2019
1	Rotavirus Infections 11/2019
1	Persistent Infection 11/2019
1	Uterine Cervical Dysplasia 04/2019
1	Ureaplasma Infections (Ureaplasma Infection) 01/2017
1	Herpes Simplex 01/2016
1	Urinary Tract Infections (Urinary Tract Infection) 08/2015
1	Chronic Hepatitis B 01/2015
1	Mycoplasma Infections 08/2013
1	Coinfection 08/2013
1	Reproductive Tract Infections 02/2011
1	Urethritis 04/2010
1	Neoplasms (Cancer) 01/2010
1	Carcinoma in Situ 01/2010
1	Uveitis 03/2003
1	Acute Retinal Necrosis Syndrome 03/2003
1	Necrosis 01/2003

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 02/2023 - 02/2011
3	Antiviral Agents (Antivirals)IBA 01/2024 - 03/2003
3	InterferonsIBA 01/2016 - 01/2003
2	VaccinesIBA 02/2023 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 03/2003
1	Antiparasitic Agents (Antiparasitics)IBA 01/2024
1	EchinocandinsIBA 10/2023
1	TriazolesIBA 10/2023
1	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2023
1	ElementsIBA 02/2022
1	Rotavirus VaccinesIBA 11/2019
1	Messenger RNA (mRNA)IBA 04/2019
1	DNA GyraseIBA 01/2017
1	Granzymes (Granzyme)IBA 01/2016
1	Lamivudine (Epivir)FDA Link 01/2015
1	Penicillins (Penicillin)FDA Link 01/2014
1	TetracyclinesIBA 08/2013
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2013
1	Josamycin (EN 141)IBA 08/2013
1	Clarithromycin (Biaxin)FDA LinkGeneric 08/2013
1	MacrolidesIBA 08/2013
1	Erythromycin (Erycette)FDA LinkGeneric 08/2013
1	Doxycycline (Periostat)FDA LinkGeneric 08/2013
1	OMPA outer membrane proteinsIBA 04/2010
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2010
1	RNA (Ribonucleic Acid)IBA 02/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003
1	CytokinesIBA 01/2003

Therapy/Procedure

5	Therapeutics 01/2024 - 03/2003
2	Aftercare (After-Treatment) 01/2022 - 04/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Gastrointestinal Endoscopes 07/2020
1	Hematopoietic Stem Cell Transplantation 11/2019